新闻
Cordlife: Reports Improved Operational Performance In 1Q2026 Despite Lower Revenue.
13 May 2026 18:02Group revenue down 6.1% year-on-year amid absence of new Singapore collections and mixed regional performance. Group loss before income tax from operations improved by 13.3%, although net loss widened by 6.8%. Gross profit margin rose to 57.9%, driven by continued cost optimisation efforts across the Group. Cord blood banking industry fundamentals remain positive, driven by growing interest in stem cell therapies and preventive healthcare...
More information available here.
Source: ShareInvestor Express
